Tochigi, Japan

Keita Miyoshi

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keita Miyoshi. Retrieved from https://idiyas.com/inventor/keita-miyoshi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keita Miyoshi: Innovator in Pharmaceutical Chemistry

Introduction

Keita Miyoshi is a prominent inventor based in Tochigi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic potential. His work focuses on creating innovative solutions that address various medical needs.

Latest Patents

Miyoshi holds a patent for "Diphenyl sulfide derivatives and medicines containing same as active ingredient." This patent describes diphenyl sulfide derivatives that exhibit excellent S1P3 antagonistic activity, making them valuable as drugs. Intensive studies led to the discovery of these compounds, which are represented by a specific general formula. The derivatives have shown promise in their ability to act as effective S1P3 antagonists.

Career Highlights

Throughout his career, Keita Miyoshi has been associated with Kyorin Pharmaceutical Co., Ltd., where he has contributed to various research initiatives. His innovative approach and dedication to pharmaceutical development have positioned him as a key figure in his field.

Collaborations

Miyoshi has collaborated with notable colleagues, including Yasushi Kohno and Kiyoshi Fujii. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Keita Miyoshi's work in developing diphenyl sulfide derivatives showcases his commitment to advancing pharmaceutical science. His contributions continue to impact the field positively, paving the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…